Peptides for Anxiety, Stress & Nervous System Support

How peptide Targets Peptides for Anxiety & Stress

Peptide-based anxiolysis works through neuromodulation rather than receptor blockade. Selank (a synthetic analog of tuftsin) modulates GABA-A receptor sensitivity, enhances serotonin metabolism, and increases BDNF expression — producing anxiolytic effects without sedation or cognitive impairment. It is approved in Russia as an anxiolytic.

DSIP (Delta Sleep-Inducing Peptide) reduces cortisol and ACTH levels while promoting delta-wave sleep — addressing the HPA axis hyperactivation and sleep disruption that perpetuate anxiety. Its mechanism involves opioid receptor modulation without being an opioid.

Semax (a synthetic ACTH analog) enhances BDNF and cognitive function. While not directly anxiolytic, it counters the cognitive impairment (brain fog, poor concentration) that often accompanies chronic anxiety and stress.

BPC-157 has demonstrated effects on dopaminergic and serotonergic systems in animal models, with some studies suggesting anxiolytic properties, though this is not its primary application.

These peptides are not replacements for therapy (CBT has the strongest evidence for anxiety disorders) or appropriate medication, but they address neurochemical dimensions that complement standard treatment.